Who mentions $ORKA most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $ORKA most — 3 mentions in the past 12 months.

When was $ORKA first mentioned on Surfaced?

The earliest tracked mention of $ORKA in the Surfaced archive was on Sep 17, 2025.

How many voices track $ORKA?

2 FinTwit voices have mentioned $ORKA 4 times in the past 12 months.

What kind of voices mention $ORKA most?

$ORKA is mentioned most by Biotech voices on Surfaced.

Last 12mo stats

mentions

voices

$ORKA

ARCA biopharma Inc

$ORKA

ARCA biopharma Inc

Past 12mo:4mentions2voices

All voices4 mentions since Sep 2025calls only

Loading price chart…

About this stock

Over the past 12 months, $ORKA has been mentioned 4 times by 2 distinct FinTwit voices, with the first mention appearing on September 17, 2025. The most recent discussion occurred on April 27, 2026. Adam Feuerstein (@adamfeuerstein) accounts for 3 of the 4 mentions, establishing himself as the primary voice discussing ARCA biopharma's ticker in this archive. The biotech category represents the dominant discussion category for $ORKA among these voices.

AI-generated from tracked posts · updated Jul 21, 2026

Frequently asked

Related stocks

$ALKSAlkermes

$ALMSAlumis

$ASNDAscendis Pharma A/S

$ATAIATAI Life Sciences

Recent mentions

4 mentions

@adamfeuersteinApr 27, 2026 · 11:09 AM

Insta-stock reaction $ORKA +45% $NTLA -1% $MANE +34%

Open on X

@adamfeuersteinApr 27, 2026 · 11:02 AM

$ORKA Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study 63% PASI 100 score at 16 weeks, very strong data. https://t.co/RJxnbuU0e3 via me

Open on X

@investmentguru_Apr 23, 2026 · 10:18 AM

THE ENERGY MAP: Every Source, Every Play Global energy investment just crossed $3.3T in 2025 — with $2.2T flowing into clean tech alone, 2× fossil fuels. The AI data center supercycle has changed everything. Power is now the bottleneck. Access to electricity > land, labor, connectivity. Here’s how the landscape is shaping up NUCLEAR — Highest Conviction The renaissance is real. Record generation, 63 reactors under construction, SMRs gaining traction with hyperscaler demand. → AI + baseload = nuclear wins Plays: $CEG $CCJ $OKLO $SMR $NNE $LEU $DNN $LTBR BATTERY STORAGE — High Conviction The backbone of 24/7 clean energy. Explosive growth + massive pipeline into 2030. → Solar pairing + grid stability + data center demand Plays: $TSLA $FLNC $STEM $AMPS $KULR $QS $MVST $AMPX GRID INFRASTRUCTURE — The Real Winner - No matter who wins, the grid must scale. Massive capex cycle just starting. → AI load + EVs + electrification = multi-year demand Plays: $CEG $NEE $ETN $PWR $VRT $HUBB $VST $AES SOLAR — Selective Still scaling globally, but policy shifts create winners & losers. → Data center PPAs absorbing higher costs Plays: $FSLR $ARRY $ENPH $NEE $RUN GEOTHERMAL — Stealth Play Underrated baseload. EGS unlocking new regions. → 24/7 clean energy = perfect for hyperscalers Plays: $CEG $ORKA $NEE NAT GAS / LNG — Bridge Fuel Not going anywhere. Reliability matters. → AI demand + LNG exports = strong tailwind Plays: $LNG $AR $EQT $SLB $HAL WIND — Watchlist Onshore steady, offshore challenged (policy + cost). → Europe still bullish Plays: $GEV $NEE $CWEN $BEP HYDROGEN — Speculative High risk, long-term potential. 2026 is pivotal. → Industrial demand is the key Plays: $PLUG $BE $LIN HYDRO — Stable Compounder Reliable baseload + long-duration storage. → Quiet outperformer in volatile markets Plays: $BEP $CWEN $NEP THE MACRO FRAME This is no longer just a climate transition. It’s a national security + AI infrastructure race. Capital flow trend: Semis → Memory → Photonics → Power & Energy → Robotics We are entering the Power wave Position accordingly. The grid wins regardless. Not financial advice. Like and share

Open on X

@adamfeuersteinSep 17, 2025 · 10:29 AM

Like old times.... The wall-crossed PIPE is back. Thank you, $ORKA! Orka raised $180M at $15 (market price) from a galaxy of biotech hedge funds - 13 funds listed in the press release, alone. All were given an advance peek at the new, first-in-human PK data for ORKA-001, Orka's long-acting IL-23 antibody, showing an approximate 100 day half life. The company says it supports the potential for once-yearly maintenance dosing in psoriasis. Phase 2a study underway, data in 2H '26. https://t.co/w3IPEcnedO

Open on X